Shield Therapeutics plc
SHIEF
Price:
$0.0901
Market Cap:
$123.06M
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults. It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company was founded in 2008 and is based in Gateshead, the United Kingdom.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-12-06
Stock Exchange
OTC
Ticker
SHIEF
PE Ratio
[-4.50]
ROE
[206.44%]
Current Ratio
[0.83]
Dividend Yield
[0%]
Enterprise Value
[139.30M]
Dividend History
The ROE as of December 2025 (TTM) for Shield Therapeutics plc (SHIEF) is 206.44%
According to Shield Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is 206.44%. This represents a change of -139.55% compared to the average of -521.93% of the last 4 quarters.
Shield Therapeutics plc (SHIEF) Historical ROE (quarterly & annually)
How has SHIEF ROE performed in the past?
The mean historical ROE of Shield Therapeutics plc over the last ten years is 95.55%. The current 206.44% ROE has changed 116.06% with respect to the historical average. Over the past ten years (40 quarters), SHIEF's ROE was at its highest in in the December 2024 quarter at 862.25%. The ROE was at its lowest in in the June 2024 quarter at -2859.45%.
Average
95.55%
Median
-29.20%
Minimum
-745.24%
Maximum
2.02%
Shield Therapeutics plc (SHIEF) ROE by Quarter and Year
Discovering the peaks and valleys of Shield Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.47%
Maximum Annual ROE = 2.02%
Minimum Annual Increase = -816.51%
Minimum Annual ROE = -745.24%
| Year | ROE | Change |
|---|---|---|
| 2024 | 2.02% | -816.51% |
| 2023 | -282.32% | -62.12% |
| 2022 | -745.24% | 1.47% |
| 2021 | -47.52% | 447.03% |
| 2020 | -8.69% | -68.27% |
| 2019 | -27.38% | 516.95% |
| 2018 | -4.44% | -90.67% |
| 2017 | -47.54% | 53.21% |
| 2016 | -31.03% | -124.48% |
| 2015 | 126.73% | 96.71% |
Shield Therapeutics plc (SHIEF) Average ROE
How has SHIEF ROE performed in the past?
The current ROE of Shield Therapeutics plc (SHIEF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
331.78%
5-year avg
187.82%
10-year avg
95.55%
Shield Therapeutics plc (SHIEF) ROE vs. Peers
How is SHIEF’s ROE compared to its peers?
Shield Therapeutics plc’s ROE is less than Orexo AB (publ) (113.81%), greater than Green Growth Brands Inc. (-311.96%), greater than Pacific Edge Limited (-89.71%), less than Cannara Biotech Inc. (16.72%), less than Jushi Holdings Inc. (99.18%), greater than Poolbeg Pharma PLC (-53.86%), less than BioSyent Inc. (22.63%), greater than HLS Therapeutics Inc. (-21.19%), greater than Grown Rogue International Inc. (-57.91%), greater than Kintor Pharmaceutical Limited (0%),
| Company | ROE | Market cap |
|---|---|---|
| 113.81% | $105.44M | |
| -311.96% | $2.06K | |
| -89.71% | $101.52M | |
| 16.72% | $111.98M | |
| 99.18% | $97.73M | |
| -53.86% | $29.63M | |
| 22.63% | $96.90M | |
| -21.19% | $108.43M | |
| -57.91% | $73.63M | |
| 0% | $94.90M |
Build a custom stock screener for Shield Therapeutics plc (SHIEF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shield Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Shield Therapeutics plc (SHIEF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Shield Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Shield Therapeutics plc's ROE?
How is the ROE calculated for Shield Therapeutics plc (SHIEF)?
What is the highest ROE for Shield Therapeutics plc (SHIEF)?
What is the 3-year average ROE for Shield Therapeutics plc (SHIEF)?
What is the 5-year average ROE for Shield Therapeutics plc (SHIEF)?
How does the current ROE for Shield Therapeutics plc (SHIEF) compare to its historical average?